News
Public · Published
Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk — Barrons.com
Amdocs shares fell 27% to $45.50 on Wednesday, their steepest percentage drop in 24 years, after a dispute with T-Mobile threatened their business relationship. Both companies issued notices accusing the other of materially breaching agreements. Amdocs forecast lower revenue, including a 14% to 18% decline in fiscal 2027.
Published:
Updated:
What happened
Amdocs shares fell 27% to $45.50 on Wednesday, their steepest percentage drop in 24 years, after a dispute with T-Mobile threatened their business relationship. Both companies issued notices accusing the other of materially breaching agreements. Amdocs forecast lower revenue, including a 14% to 18% decline in fiscal 2027.
Confirmed
Global impact / market context
The dispute creates a direct risk to Amdocs’ revenue because T-Mobile is a customer under agreements for software and services. Amdocs says its fiscal 2027 outlook allows for those agreements to end, while its first-quarter revenue forecast is already well below analysts’ consensus expectation.
Analyst inference
Amdocs’ outlook also includes sales of business activities and exits from some hardware resale work, so the forecast decline is not attributed solely to T-Mobile. The article reports no resolution, making the contract dispute and its effect on future sales key uncertainties for investors.
Analyst inference
What to watch
- Watch for updates on the notices each company issued and whether either side takes further action over its claim that the other materially breached their agreements. Analyst inference
- Amdocs said its fiscal 2027 guidance allows for possible termination of the T-Mobile agreements; whether that outcome occurs remains unresolved in the article. Confirmed
- Compare upcoming revenue updates with Amdocs’ first-quarter forecast of $955 million to $995 million and its fiscal 2027 decline forecast of 14% to 18%. Analyst inference
Evidence
- Original source link unavailable